The cost of Targeted Therapy in India typically ranges between USD 8000 - USD 12000.
However, this cost can vary depending on several factors, including the type and severity of the condition, treatment techniques chosen, the healthcare facility's location and reputation, the treating professionals' experience and specialisation, and the patient's overall health status.
Additionally, factors like the duration of treatment, the need for follow-up care, and the use of advanced technologies or specialised treatments can further influence the overall cost.
The goal of targeted therapy, a type of cancer treatment, is to target genetic alterations or mutations that cause healthy cells to develop into cancerous ones. To employ targeted therapy, medical professionals look for genetic alterations that cause cancer cells to proliferate and endure. They then pinpoint particular therapies to eradicate or stop those cells' growth. Medical professionals can avoid harming healthy cells by treating cancer cells with targeted therapy. To treat various types of cancer, medical professionals have created over 80 targeted therapies. Occasionally, targeted therapy is used as the first line of treatment. Additionally, targeted therapy may be used in conjunction with other therapies.
| City | Minimum Cost (USD) | Minimum Cost (INR) | Maximum Cost (USD) | Maximum Cost (INR) |
|---|---|---|---|---|
| Amroha | USD 6400 | 548096 | USD 9600 | 822144 |
| Bangalore | USD 8000 | 685120 | USD 12000 | 1027680 |
| Chennai | USD 8000 | 685120 | USD 12000 | 1027680 |
| Delhi | USD 8000 | 685120 | USD 12000 | 1027680 |
| Delhi Ncr | USD 8000 | 685120 | USD 12000 | 1027680 |
| Faridabad | USD 8000 | 685120 | USD 12000 | 1027680 |
| Ghaziabad | USD 8000 | 685120 | USD 12000 | 1027680 |
| Gurgaon | USD 8000 | 685120 | USD 12000 | 1027680 |
| Gurugram | USD 8000 | 685120 | USD 12000 | 1027680 |
| Hyderabad | USD 8000 | 685120 | USD 12000 | 1027680 |
| Kochi | USD 8000 | 685120 | USD 12000 | 1027680 |
| Kolkata | USD 8000 | 685120 | USD 12000 | 1027680 |
| Mumbai | USD 8000 | 685120 | USD 12000 | 1027680 |
| Noida | USD 8000 | 685120 | USD 12000 | 1027680 |
| Panjim | USD 7200 | 616608 | USD 10800 | 924912 |
| Country | Minimum Cost | Minimum Local Currency | Maximum Cost | Maximum Local Currency |
|---|---|---|---|---|
| India | USD 8000 | INR 685120 | USD 12000 | INR 1027680 |
| Lithuania | USD 2000 | LTL 6841 | USD 10000 | LTL 34207 |
| Malaysia | USD 2000 | MYR 8480 | USD 10000 | MYR 42400 |
| Singapore | USD 10000 | SGD 12900 | USD 50000 | SGD 64500 |
| Thailand | - | - | USD 3500 | THB 114485 |
| Tunisia | USD 2000 | TND 5960 | USD 20000 | TND 59600 |
| Turkey | USD 7500 | TRY 292950 | USD 12000 | TRY 468720 |
| United Arab Emirates | USD 5500 | AED 20185 | USD 54000 | AED 198180 |
Need Help Planning Your Treatment Abroad?
Your 24/7 AI Health Assistant 
Targeted therapy is a cancer treatment that uses medicines or other chemicals to precisely identify and attack specific cancer cells. A targeted therapy can be used alone or in combination with other therapies like traditional or standard chemotherapy, surgery, or radiation therapy. Precision medicine or personalised medicine are terms used to describe targeted therapy. Small and large molecule (Monoclonal antibodies) medications are the two types of targeted therapies.
Targeted therapy is frequently used in conjunction with chemotherapy and other therapies by doctors. Targeted therapy for a variety of tumours have been approved by the US Food and Drug Administration (FDA). Types of cancers treated through Targeted Therapy are Breast cancer, Bladder cancer, Colorectal cancer, Kidney cancer, Leukemia, Liver cancer, Lung cancer, Lymphoma, and Prostate cancer
Would you like some help? We are available.
Get Help
Delhi, India
BLK-Max Super Speciality Hospital, located in New Delhi, is the leading best-in-class healthcare institution in India, providing tertiary and quaternary care. 650 + beds including 162 critical care beds, 22 OTs with 1,500+ clinical professionals allied to health are at the hospital's disposal. JCI, NABH, and NABL accredited. The hospitals are a leader in transplants, cancer care, and robotic surgery education and implementation. Established in1959 by Dr. B.L. Kapur, the hospital combines state-of-the-art technology with patient-centric values including compassion, efficiency, and consistency.

Gurgaon, India
Artemis Hospital, established in 2007 in Gurgaon, India, is a 750+ bed, state-of-the-art multi-speciality hospital and the first in Gurgaon accredited by JCI and NABH. A flagship of the Apollo Tyres Group, it offers advanced care across cardiology, oncology, orthopaedics, neurology, and transplant medicine, supported by modern infrastructure and 60+ world-class operating theatres. Its Centres of Excellence span critical areas like heart, cancer, neurosciences, orthopaedics, and women & child care. Guided by values of Service, Compassion, and Integrity, Artemis combines innovation, technology, and affordability, making it a trusted international healthcare destination for comprehensive and compassionate patient care.

Gurgaon, India
Medanta – The Medicity, Gurugram, founded by renowned cardiac surgeon Dr. Naresh Trehan, is a leading multi-super speciality hospital offering advanced yet affordable healthcare. Spread across a 43-acre campus, it houses 1,391 beds, 270 ICU beds, 40 operation theatres, and 900+ doctors across 30+ specialities. Accredited by JCI, NABH, and NABL, Medanta is designed per American Institute of Architects’ healthcare guidelines. Recognised as the Best Private Hospital in India (2020–2025) and among the World’s Top 250 Hospitals (Newsweek 2024), it excels in Cardiac Care, Cancer, Neurosciences, Gastro, Orthopaedics, and Renal Care, ensuring world-class, collaborative, and compassionate treatment.

Mumbai, India

Ghaziabad, India

Gurgaon, India

Delhi, India
Indraprastha Apollo Hospital is known for delivering treatment to over 200,000 patients every year; 10,000 of which are generally medical tourists. The efficient team of doctors has the record of 99.6 percent success rate. Indraprastha Apollo Hospital deals in treatment of over 50 specialities.
Let’s see some of the features of the infrastructure:

Hyderabad, India
Apollo Hospitals located in Hyderabad, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:

Hyderabad, India
Star Hospitals located in Hyderabad, India is accredited by NABH, NABL. Also listed below are some of the most prominent infrastructural details:

Mumbai, India
Sterling Wockhardt Hospital located in Mumbai, India is accredited by NABH. Also listed below are some of the most prominent infrastructural details:
Need Some Advice From Our Experts?
Our team of healthcare experts would be happy to assist you

+99







Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Our network connects you with the leading medical tourism destinations globally, offering a wide range of cities, top doctors, and flexible pricing options.




Different hospitals have different pricing policy when it comes to the cost of Targeted Therapy in India. The top hospitals for Targeted Therapy in India covers all the expenses related to the pre-surgery investigations of the candidate. The comprehensive Targeted Therapy package cost includes the cost of investigations, surgery, medicines and consumables. There are many things that may increase the cost of Targeted Therapy in India, including prolonged hospital stay and complications after the procedure.
Many hospitals in India perform Targeted Therapy. Some of the best hospitals for Targeted Therapy in India include the following:
While the speed of recovery may vary from patient to patient, they are still required to stay for about 25 days after discharge. This is important to ensure that the surgery was successful. During this time, control and follow-up tests take place to check for medical fitness.
Apart from the Targeted Therapy cost, there are a few other daily charges that the patient may have to pay. These are the charges for daily meals and accommodation outside the hospital. The extra charges may start from USD 50 per person.
There are many cities that offer Targeted Therapy in India, including the following:
It is possible for patients to opt for video telemedicine consultation before they come for Targeted Therapy in India. Some of the surgeons offering this service include the following
| Doctor | Cost | Schedule Your Appointment |
|---|---|---|
| Dr. Shivam Vatsal Agarwal | USD 14 | Schedule Now |
| Dr. Dinesh Chandra Katiyar | USD 35 | Schedule Now |
| Dr. Sunil Kumar Gupta | USD 35 | Schedule Now |
| Dr. Dinesh Pendharkar | USD 14 | Schedule Now |
| Dr. Sumant Gupta | USD 14 | Schedule Now |
| Dr. Gurdeep Singh Sethi | USD 44 | Schedule Now |
The average duration of stay at the hospital after Targeted Therapy is about 1 days for proper care and monitoring. The doctors team review the patient's recovery during this time with the help of blood tests and imaging scans. Once they feel that everything is on track, the patient is discharged.
The average rating for Targeted Therapy hospitals in India is 3.9. Several parameters such as hospital infrastructure, pricing policy, quality of services, politeness of staff etc. contribute to the rating.
There are more than 3 hospitals that offer Targeted Therapy in India. Such hospitals have the required infrastructure and a dedicated unit where patients can be treated. Apart from good services, the hospitals are known to follow all standard and legal guidelines as dictated by the local medical affairs body or organization.

Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More